NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -99.9% | 237 | -5.2% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 250 | -37.5% | 0.00% | – |
| Q1 2022 | $5,000 | +400.0% | 400 | +1042.9% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | -50.0% | 35 | -45.3% | 0.00% | – |
| Q1 2020 | $2,000 | – | 64 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2019 | $21,000 | -43.2% | 619 | -43.6% | 0.00% | +50.0% |
| Q4 2018 | $37,000 | -78.1% | 1,097 | -60.5% | 0.00% | -71.4% |
| Q3 2018 | $169,000 | +108.6% | 2,775 | +67.8% | 0.01% | +133.3% |
| Q2 2018 | $81,000 | -19.8% | 1,654 | -2.4% | 0.00% | -40.0% |
| Q1 2018 | $101,000 | 0.0% | 1,694 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $101,000 | +152.5% | 1,694 | +0.5% | 0.01% | +150.0% |
| Q3 2017 | $40,000 | +21.2% | 1,686 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $33,000 | -45.9% | 1,686 | -34.8% | 0.00% | -66.7% |
| Q1 2017 | $61,000 | +205.0% | 2,586 | +55.3% | 0.00% | +200.0% |
| Q4 2016 | $20,000 | -28.6% | 1,665 | +0.7% | 0.00% | 0.0% |
| Q3 2016 | $28,000 | +33.3% | 1,653 | +10.2% | 0.00% | 0.0% |
| Q2 2016 | $21,000 | 0.0% | 1,500 | +142.3% | 0.00% | -66.7% |
| Q1 2016 | $21,000 | -22.2% | 619 | -61.0% | 0.00% | +50.0% |
| Q4 2015 | $27,000 | – | 1,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |